Found: 9
Select item for more details and to access through your institution.
Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.919652
- By:
- Publication type:
- Article
Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study).
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5307, doi. 10.3390/cancers14215307
- By:
- Publication type:
- Article
Case Report: Dacomitinib May Not Benefit Patients Who Develop Rare Compound Mutations After Later-Line Osimertinib Treatment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.649843
- By:
- Publication type:
- Article
Anoikis-Related Long Non-Coding RNA Signatures to Predict Prognosis and Immune Infiltration of Gastric Cancer.
- Published in:
- Bioengineering (Basel), 2024, v. 11, n. 9, p. 893, doi. 10.3390/bioengineering11090893
- By:
- Publication type:
- Article
Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR‐mutant non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 24, p. 2327, doi. 10.1111/1759-7714.15021
- By:
- Publication type:
- Article
RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS‐mutated lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1368, doi. 10.1111/1759-7714.14882
- By:
- Publication type:
- Article
Remarkable response of BRAF<sup>V600E</sup>-mutated metastatic pancreatic cancer to BRAF/MEK inhibition: a case report.
- Published in:
- Gastroenterology Report, 2022, v. 10, p. 1, doi. 10.1093/gastro/goab031
- By:
- Publication type:
- Article
Chromothripsis is a novel biomarker for prognosis and differentiation diagnosis of pancreatic neuroendocrine neoplasms.
- Published in:
- MedComm, 2024, v. 5, n. 7, p. 1, doi. 10.1002/mco2.623
- By:
- Publication type:
- Article
Remarkable Response of EGFR- and HER2- Amplified Metastatic Colon Cancer to Pyrotinib After Failed Multiline Treatments: A Case Report and Literature Review.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.548867
- By:
- Publication type:
- Article